Congrats to Drs. Marini, Wang, and Sibille in the funding of their R21 study funded by the NIA titled “Medical marijuana and chronic musculoskeletal pain in older adults: a multi-level, precision medicine analysis.”
To study will delineate multi-level factors contributing to heterogeneous responses to medical marijuana treatment involving: (a) genetic, through targeted gene expression; (b) sociodemographic and (c) psychological/behavioral including consideration for comorbidities and medical marijuana treatment regimen.